IL DONG PHARMACEUTICAL CO., LTD. — Investor Relations & Filings
IL DONG PHARMACEUTICAL CO., LTD. is a pharmaceutical company engaged in the research, development, manufacturing, and commercialization of a broad range of healthcare products. The company's portfolio encompasses ethical drugs, over-the-counter (OTC) medications, active pharmaceutical ingredients (APIs), and health functional foods. Key therapeutic areas of focus include metabolic disorders, gastrointestinal diseases, degenerative diseases, oncology, and cardiovascular conditions. Its robust research and development pipeline features promising drug candidates such as an oral GLP-1 receptor agonist for diabetes and obesity, a P-CAB class treatment for peptic ulcers, and a first-in-class CXCR7 agonist for fibrotic diseases. Utilizing its GMP-certified facilities, the company also offers contract manufacturing (CMO) services, with specialized capabilities in antibiotics and oncology drugs, while actively pursuing global expansion through strategic partnerships and licensing.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 영업(잠정)실적(공정공시) | 2025-02-07 | Korean | |
| 결산실적공시예고(안내공시) | 2025-02-04 | Korean | |
| 매출액또는손익구조30%(대규모법인은15%)이상변경 | 2025-02-03 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2024-12-24 | Korean | |
| 전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시) | 2024-12-20 | Korean | |
| 투자판단관련주요경영사항 | 2024-12-19 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
3 filings
| |||||
| 7985853 | 영업(잠정)실적(공정공시) | 2025-02-07 | Korean | ||
| 7987888 | 결산실적공시예고(안내공시) | 2025-02-04 | Korean | ||
| 7988476 | 매출액또는손익구조30%(대규모법인은15%)이상변경 | 2025-02-03 | Korean | ||
|
2024
12 filings
| |||||
| 8000916 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2024-12-24 | Korean | ||
| 8001704 | 전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시) | 2024-12-20 | Korean | ||
| 8002321 | 투자판단관련주요경영사항 | 2024-12-19 | Korean | ||
| 8003500 | 주주명부폐쇄기간또는기준일설정 | 2024-12-16 | Korean | ||
| 8017202 | 분기보고서 (2024.09) | 2024-11-14 | Korean | ||
| 8022836 | 영업(잠정)실적(공정공시) | 2024-10-30 | Korean | ||
| 8022830 | 연결재무제표기준영업(잠정)실적(공정공시) | 2024-10-30 | Korean | ||
| 8045141 | 결산실적공시예고(안내공시) | 2024-10-28 | Korean | ||
| 8074158 | 주식등의대량보유상황보고서(일반) | 2024-09-26 | Korean | ||
| 8074146 | 최대주주등소유주식변동신고서 | 2024-09-26 | Korean | ||
| 8094474 | 반기보고서 (2024.06) | 2024-08-14 | Korean | ||
| 8098237 | 주식등의대량보유상황보고서(약식) | 2024-08-12 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
IL DONG PHARMACEUTICAL CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/17166/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=17166 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=17166 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=17166 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 17166}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IL DONG PHARMACEUTICAL CO., LTD. (id: 17166)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.